AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
JAMA Clinical Reviews
Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections
Jun 12, 2024
Expert in critical care medicine, Romain Pirracchio, discusses the benefits of using low-dose corticosteroids in treating severe pulmonary infections. Topics include the use of corticosteroids in COVID-19 cases, positive impacts on mortality in Community-Acquired Pneumonia, and guidelines for timely initiation of treatment in critically ill patients.
17:20
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Shift from high- to low-dose corticosteroids due to inflammation balance.
- Meta-analysis shows low-dose corticosteroids reduce mortality and respiratory support need in severe CAP.
Deep dives
Use of Low-Dose Corticosteroids for Severe Pulmonary Infections
Dr. Perrecchio discusses the importance of managing severe pulmonary infections, which are a leading cause of adult mortality. The shift from high-dose to low-dose corticosteroids due to new understandings of inflammation balance is highlighted. The definition of low-dose corticosteroids, including doses below 400 milligrams per day of hydrocortisone equivalents, is explained. Specific examples from COVID-19 treatment protocols with 6 milligrams of dexamethasone daily are mentioned.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode